Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial

Tjan-Heijnen, V.C.G.; Hellemond, I.E.G. van; Peer, P.G.M.; Swinkels, A.C.P.; Smorenburg, C.H.; Sangen, M.J.C. van der; ... ; Dutch Breast Canc Res Grp B (2017)

Article / Letter to editor

• All authors: Tjan-Heijnen, V.C.G.; Hellemond, I.E.G. van; Peer, P.G.M.; Swinkels, A.C.P.; Smorenburg, C.H.; Sangen, M.J.C. van der; Kroep, J.R.; Graaf, H. de; Honkoop, A.H.; Erdkamp, F.L.G.; Berkmortel, F.W.P.J. van den; Boer, M. de; Roos, W.K. de; Linn, S.C.; Imholz, A.L.T.; Seynaeve, C.M.; Dutch Breast Canc Res Grp B
• Date: 2017-11-30
• Journal: The Lancet Oncology
• Volume: 18
• Issue: 11
• Pages: 1502 - 1511
• DOI: doi:10.1016/S1470-2045(17)30600-9